ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

AVTI Avitar Inc (CE)

0.000001
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Avitar Inc (CE) USOTC:AVTI OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.000001 0.00 01:00:00

Avitar, Inc. Retains The Investor Relations Group

13/07/2006 2:45pm

PR Newswire (US)


Avitar (CE) (USOTC:AVTI)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Avitar (CE) Charts.
CANTON, Mass., July 13 /PRNewswire-FirstCall/ -- AVITAR, Inc. (OTC:AVTI) (BULLETIN BOARD: AVTI) , developer of the world's first rapid, on-site, fluid-based oral screening test for drugs-of-abuse, has retained The Investor Relations Group, Inc. (IRG), a full-service investor relations firm, to serve as its new investor relations, corporate communications and public relations agency. "The Investor Relations Group will play an integral role in ensuring Avitar's story reaches the investment community, as well as the trade and consumer media," said Pete Phildius, CEO and Chairman of Avitar. "We believe IRG will help us deliver our Company messages more effectively to investors as well as media sources." IRG will strive to increase investor and industry awareness of Avitar and its brands within the U.S. and world markets by introducing the Company and its management to pre-qualified fund managers and analysts, as well as financial and industry media sources. About Avitar, Inc. Avitar, Inc. develops, manufactures and markets innovative and proprietary products. Its field includes the oral fluid diagnostic market, the disease and clinical testing market, and customized polyurethane applications used in the wound dressing industry. Avitar manufactures ORALscreen(R) the world's first non-invasive, rapid, on-site, fluid-based oral screening test for drugs- of-abuse, as well as HYDRASORB(R), an absorbent topical dressing for moderate to heavy exudating wounds. Avitar is also developing diagnostic strategies for disease and clinical testing in the estimated $25 billion in-vitro diagnostics market. Conditions targeted include influenza, diabetes, and pregnancy. For more information, visit Avitar's Web site at http://www.avitarinc.com/. About The Investor Relations Group, Inc. The Investor Relations Group, Inc. (IRG), founded in 1996, represents select publicly traded companies, with a unique specialization in assisting quality under-followed companies. IRG arranges one-on-one meetings for its portfolio companies with pre-qualified money managers, handling investment portfolios that range from $10 million to $10 billion+, selected from its proprietary contact base of more than 50,000 qualified fund managers with an investing history in small-cap stocks. IRG is a full-service corporate communications company that, among other related offerings, produces all client press releases, manages shareholder communications and acts as primary contact for the investing community. IRG also houses a full-service public relations arm that specializes in building awareness of its companies within the financial and trade media, as well as the public at large. Forward-Looking Statements This release contains forward looking statements that are subject to risks and uncertainties including the development and marketing of new applications and other risks that are detailed from time to time in the Company's filings with the Securities and Exchange Commission. In view of such risks and uncertainties, the Company's actual results could differ materially from those anticipated in such forward looking statements. Contact: Jay C. Leatherman Avitar, Inc. +1-781-821-2440 http://www.avitarinc.com/ The Investor Relations Group Investors: Erika Moran / Tom Caden, +1-212-825-3210 Media: Susan Morgenbesser, +1-212-825-3210 DATASOURCE: AVITAR, Inc. CONTACT: Jay C. Leatherman of Avitar, Inc., +1-781-821-2440, ; or Erika Moran or Tom Caden, +1-212-825-3210, , , both of The Investor Relations Group; or Susan Morgenbesser, +1-212-825-3210 Web site: http://www.avitarinc.com/

Copyright

1 Year Avitar (CE) Chart

1 Year Avitar (CE) Chart

1 Month Avitar (CE) Chart

1 Month Avitar (CE) Chart

Your Recent History

Delayed Upgrade Clock